The antihypertensive medicine market in Italy is forecasted to decline steadily from 2024 to 2028, with a year-on-year drop in sales value of approximately 4.7%. As we stand in 2024, the market is valued at $169.4 million, highlighting a negative growth trend projected over the next five years, reaching $137.7 million by 2028. The Compound Annual Growth Rate (CAGR) for this period reflects a decrease of about 5.0% annually. This declining trend signifies potential shifts in market dynamics or changes in healthcare practices.

Future trends to watch for include:

Advancements in antihypertensive drug development potentially altering market dynamics.
Changes in regulatory frameworks impacting medication affordability and accessibility.
Rising awareness and adoption of preventive healthcare measures affecting pharmaceutical demand.